| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |